The performance of the EQ-5D-Y-5L compared to the EQ-5D-Y-3L in children and adolescents with cerebral palsy (CP).

Dialogues Health

Faculty of Health and Rehabilitation Sciences, Division of Physiotherapy, Cape Town, South Africa.

Published: December 2022


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Objectives: The aim of this study is to compare the performance and validity of the EQ-5D-Y-3L (Y-3L) and EQ-5D-Y-5L (Y-5L) in South African children and adolescents with cerebral palsy (CP).

Methods: Children/adolescents with CP and those from the general population completed the Y-5L, Y-3L, and PedsQL. Physiotherapists at the school classified participants' functional ability on the Gross Motor Functioning Classification System (GMFCS).

Results: Fifty-one children/adolescents completed the measures. The ceiling effect had a 44% relative reduction for and floor effects decreased across all dimensions except for when moving from the Y-3L to Y-5L. Informativity of dimensions improved on average by 0.27 on the Y-5L with similar evenness. There was a range of 6-16% inconsistent responses when moving from the Y-3L to the Y-5L. Convergent validity was strong on paired Y-3L and Y-5L dimensions: Kendall's Tau B (range 0.53 - 0.85) and Gamma (range 0.79 - 0.99). There was significant moderate association between Y-3L and Y-5L with similar items on the PedsQL. The physical dimensions of and were significantly associated with GMFCS with those having less independent mobility reporting more severe problems on dimension scores.

Conclusion: The Y-5L showed a notable reduction in ceiling and floor effects, improved discriminatory power, higher criterion validity with the GMFCS and similar concurrent validity with the PedsQL as the Y-3L. It is recommended that the Y-5L is further tested for reliability and responsiveness in this population group so that its utility for detecting change in clinical trials or as a routine outcome measure can be determined.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10953924PMC
http://dx.doi.org/10.1016/j.dialog.2022.100032DOI Listing

Publication Analysis

Top Keywords

y-3l y-5l
16
y-5l
9
children adolescents
8
adolescents cerebral
8
cerebral palsy
8
floor effects
8
moving y-3l
8
y-3l
7
performance eq-5d-y-5l
4
eq-5d-y-5l compared
4

Similar Publications

Objectives: This study evaluated and compared the psychometric properties (ceiling effects, construct validity, and responsiveness) of EQ-5D-Y-3L (Y-3L), EQ-5D-Y-5L (Y-5L), and child health utility 9D (CHU9D) in pediatric patients with eczema.

Methods: Patients completed the Y-3L, Y-5L, CHU9D, and the Child Dermatology Life Quality Index and were followed up during their next visit. Clinicians assessed patients' skin status using the Validated Investigator Global Assessment scale for Atopic Dermatitis.

View Article and Find Full Text PDF

Measuring and Valuing Health Using EuroQol Instruments: New Developments 2025 and Beyond.

Appl Health Econ Health Policy

July 2025

EuroQol Research Foundation, Rotterdam, The Netherlands.

The health-related quality of life (HRQoL) instruments developed by EuroQol, an international not-for-profit organisation, have earned a unique position in health economics and outcomes research. The original instrument, EQ-5D-3L, aimed to provide a concise, generic way of measuring and valuing HRQoL in adults that would enable broad comparability of HRQoL across populations and facilitate estimation of quality-adjusted life years (QALYs). These goals remain central to efforts to develop new instruments; to strengthen methods and evidence in measuring and valuing HRQoL; and to expand the use of HRQoL evidence to improve decision making.

View Article and Find Full Text PDF

Objectives: We compared the measurement properties of 2 proxy versions (proxy-proxy perspective, P1 and proxy-patient perspective, P2) of EQ-5D-Y-3L (Y-3L) and EQ-5D-Y-5L (Y-5L) for assessing the health-related quality of life (HRQoL) of pediatric patients with asthma or eczema.

Methods: We recruited pediatric patients with asthma or eczema and their parents or legal guardians from 2 tertiary hospitals in Singapore. Patients completed Y-3L, Y-5L, and a disease-specific HRQoL questionnaire.

View Article and Find Full Text PDF

Comparisons of Preferences Toward EQ-5D-Y-3L Health States Between Adult Own and Child Perspectives.

Value Health

September 2025

Department of Family Medicine and Primary Care, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China; Laboratory of Data Discovery for Health (D24H), Hong Kong Science Park, Hong Kong SAR, China; Department of Infectious Disease Epidemiology, London

Objectives: The international valuation protocol for EQ-5D-Y-3L recommends elicitation of utilities using adults' preference for a hypothetical 10-year-old child. Published studies have reported preference difference in adults when valuing for a child and valuing for themselves. This study aimed to obtain EQ-5D-Y-3L preferences in Hong Kong and understand the preference difference between the adult own perspective and the child perspective.

View Article and Find Full Text PDF

Validation of EuroQol instruments in paediatric patients and their caregivers in China: protocol for a prospective observational study.

BMJ Open

June 2025

Department of Psychiatry, Section of Medical Psychology and Psychotherapy, Erasmus MC, Rotterdam, The Netherlands.

Introduction: The EQ-5D-Y (the youth version of EQ-5D) is widely used to assess children's health-related quality of life (HRQoL), yet its psychometric properties across administration modes remain insufficiently explored, particularly in paediatric oncology and rare diseases. Additionally, the broader impact of childhood illness on family caregivers (spillover effects) is underexamined. This study aims to evaluate the validity, reliability and responsiveness of the three-level version of EQ-5D-Y (EQ-5D-Y-3L) and the five-level version of EQ-5D-Y (EQ-5D-Y-5L) across different modes while also assessing the EQ-5D five-level version (EQ-5D-5L) and the new EQ Health and Well-being Short Version (EQ-HWB-9) in capturing spillover effects.

View Article and Find Full Text PDF